Please provide your email address to receive an email when new articles are posted on . Published findings report that, for vascular access in hemodialysis, the creation of an arteriovenous fistula ...
When it comes to dialysis, one method of accessing the blood to clean it gets championed above the rest. But quite a few specialists say there's not enough evidence to universally support the ...
A new study shows that for those individuals with chronic kidney disease, it doesn't matter if you're young or old: arteriovenous (AV) fistulas remain the gold standard for maintaining access to one's ...
A two-day conference on controversies in Dialysis Access Asia-Pacific (CiDAAP) began at the Hyatt Regency in Gurgaon. Debates, discussions and a competitive challenge among interventional radiologists ...
One-third of older patients with end-stage kidney disease received an arteriovenous fistula within 6 months of starting ...
If you’re living with advanced kidney disease, preparing for dialysis can feel overwhelming. One crucial decision is how your blood will be accessed for treatment. While there are different options, ...
Discover why kidney care teams are rethinking vascular access strategies for dialysis patients. For years, the “Fistula First” initiative dominated treatment decisions, but new evidence and updated ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A new device for the percutaneous creation of an arteriovenous fistula (AVF) for hemodialysis access in patients with kidney disease has excellent cumulative patency rates out to 2 years and is ...
For those who have suffered a kidney failure, dialysis provides a new lease of life. During dialysis, the blood from a patient's body is taken to a machine, cleaned and returned. The machine functions ...
When it comes to dialysis, one method of accessing the blood to clean it gets championed above the rest. But quite a few specialists say there's not enough evidence to universally support the ...